A process for continuous, on-demand production of dilute acrolein liquid on-site, at or near the point of acrolein injection, by the liquid dehydration of glycerol in an improved tubular reactor where non-aqueous glycerol is combined with a heteropolyacid catalyst, including silicotungstic acid, phosphotungstic acid, or phosphomolybdic acid. The acid catalyst is evenly dissolved and dispersed in the glycerol upstream of the reactor vessel. The reaction is conducted in a tubular reactor which is heated to an elevated reaction temperature. The dilute acrolein produced in the tubular reactor is directed downstream, optionally through a liquid-liquid heat exchanger and then an air-liquid heat exchanger to reduce temperature, and then diluted prior to being injected into sulfide contaminated systems (such as oil & gas water floods, water disposal systems, producing oil wells, and fuel oil storage) via a pressure conduit.

In a method for producing an aliphatic carboxylic acid ester by reacting an aliphatic carboxylic acid having from 1 to 5 carbon atoms and an olefin having from 2 to 4 carbon atoms in a gas phase by use of a solid acid catalyst, a solid acid catalyst in which a heteropolyacid or a salt thereof is supported on a silica carrier obtainable by kneading fumed silica obtained by a combustion method, silica gel obtained by a gel method, and colloidal silica obtained by a sol-gel method or a water glass method, molding the resulting kneaded product, and calcining the resulting molded body, is used.

A multi-catalytic material that includes a polyelectrolyte membrane and methods of preparing the same are provided herein.

A multi-catalytic material that includes a polyelectrolyte membrane and methods of preparing the same are provided herein.

Disclosed herein is a fungicide, including: a porous carbon material; and a silver member adhered to the porous carbon material, wherein a value of a specific surface area based on a nitrogen BET, namely Brunauer, Emmett, and Teller method is equal to or larger than 10 m.sup.2/g, and a volume of a fine pore based on a BJH, namely Barrett, Joyner, and Halenda method and an MP, namely Micro Pore method is equal to or larger than 0.1 cm.sup.3/g.

Hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof are dehydrated using a catalyst and a method to produce bio-acrylic acid, acrylic acid derivatives, or mixtures thereof. A method to produce the dehydration catalyst is also provided.

The invention relates to a multi-stage medical sewage sterilization device and method based on graphene nano technologies. The multi-stage sterilization device comprises multiple stages of graphene nano composite sterilization grids, a graphene photocatalytic sterilization tank, a graphene-modified diatom ceramic disinfection tank, an ultrasonic sterilization tank and a laser and near-infrared sterilization device. Compared with a traditional method, the present invention has a more thorough killing or blocking effects on pathogenic bacteria, parasite eggs and the like in various medical sewages. In addition, the device of the present invention can be disassembled and cleaned regularly, and has a long service life, thus the process cost is reduced.

There is described a hydroprocessing process of at least one gas oil cut having a weighted mean temperature (TMP) between 240 C. and 350 C. using a catalyst comprising at least one metal of the group VIB and/or at least one metal of the group VIII of the periodic classification and a support comprising an amorphous mesoporous alumina having a connectivity (Z) greater than 2.7, the hydroprocessing process operating at a temperature between 250 C. and 400 C., at a total pressure between 2 MPa and 10 MPa with a ratio of hydrogen volume to volume of hydrocarbon-containing feedstock between 100 and 800 litres per litre and at an Hourly Volume Rate (HVR) which is defined by the ratio of the volume flow rate of liquid hydrocarbon-containing feedstock to volume of catalyst fed into the reactor between 1 and 10 h.sup.1.

There is described a hydroprocessing process of at least one gas oil cut having a weighted mean temperature (TMP) between 240 C. and 350 C. using a catalyst comprising at least one metal of the group VIB and/or at least one metal of the group VIII of the periodic classification and a support comprising an amorphous mesoporous alumina having a connectivity (Z) greater than 2.7, the hydroprocessing process operating at a temperature between 250 C. and 400 C., at a total pressure between 2 MPa and 10 MPa with a ratio of hydrogen volume to volume of hydrocarbon-containing feedstock between 100 and 800 litres per litre and at an Hourly Volume Rate (HVR) which is defined by the ratio of the volume flow rate of liquid hydrocarbon-containing feedstock to volume of catalyst fed into the reactor between 1 and 10 h.sup.1.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.